All posts by: Michael Zand

About Michael Zand

Drugmakers see a pricing blueprint in an $850000 gene therapy – TODAYonline

Continue reading

2018-01-12 NEWS

TODAYonline

Drugmakers see a pricing blueprint in an $850000 gene therapy
TODAYonline
SAN FRANCISCO – Global drugmakers are looking to a tiny biotech’s $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines. Spark Therapeutics Inc <ONCE.O> plans to launch its

and more »

Continue reading

2018-01-12 NEWS

WIRED

Clashes Over the Future of Gene Therapy at the US’s Biggest Biotech Meeting
WIRED
others came to celebrate the very real, very current progress of a field 30 years in the making: gene therapy. And the promise of a much newer technology, Crispr, to propel the long-standing field forward with even greater momentum. After decades of

and more »